Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 202,989 | 137,266 | 37,499 | 30,423 | 186,309 |
| Marketable Securities | 318,363 | 202,073 | 91,629 | 192,785 | 95,383 |
| Receivables | 911 | 1,035 | 790 | 1,378 | 350 |
| Other current assets | 0 | 23,849 | 0 | 0 | 0 |
| TOTAL | $532,400 | $368,987 | $134,554 | $230,935 | $285,790 |
| Non-Current Assets | |||||
| PPE Net | 21,227 | 1,080 | 41,362 | 42,634 | 46,417 |
| Intangibles | 97,900 | 97,900 | 98,100 | 98,100 | 98,100 |
| Other Non-Current Assets | 433 | 3,409 | 144 | 109 | 205 |
| TOTAL | $119,560 | $102,389 | $139,606 | $140,843 | $144,722 |
| Total Assets | $651,960 | $471,376 | $274,160 | $371,778 | $430,512 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,976 | 20,167 | 1,710 | 1,574 | 1,443 |
| Accounts payable and accrued liabilities | 19,725 | 13,064 | 9,715 | 7,661 | 6,042 |
| Accrued Expenses | 24,757 | 10,120 | 7,674 | 8,922 | 13,786 |
| TOTAL | $122,957 | $44,969 | $19,294 | $18,285 | $21,390 |
| Non-Current Liabilities | |||||
| Long Term Debt | 100,960 | 87,500 | 20,167 | 21,877 | 23,451 |
| Deferred Revenues | 76,499 | 1,618 | 195 | 128 | 119 |
| Other Non-Current Liabilities | 14,367 | 23,535 | 32,386 | 32,283 | 55,146 |
| TOTAL | $243,153 | $142,389 | $84,703 | $86,815 | $111,554 |
| Total Liabilities | $366,110 | $187,358 | $103,997 | $105,100 | $132,944 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 103,770 | 103,623 | 73,421 | 73,308 | 68,672 |
| Common Shares | 104 | 104 | 514 | 512 | 480 |
| Retained earnings | -1,108,934 | -1,104,252 | -1,003,958 | -899,832 | -789,621 |
| Other shareholders' equity | 34 | -453 | 499 | 393 | -324 |
| TOTAL | $285,850 | $284,018 | $170,163 | $266,678 | $297,568 |
| Total Liabilities And Equity | $651,960 | $471,376 | $274,160 | $371,778 | $430,512 |